Verana Health
Robert Ghenchev currently serves as Managing Partner for Growth Investments at Novo Holdings since January 2018 and holds multiple board member positions at Verana Health, Quanta Dialysis Technologies, Oxford Biomedica, MightyOwl, Exscientia, Tempus AI, and Mission Bio. Prior experience includes roles in Healthcare Investment Banking at Moelis & Company and UK Mergers & Acquisitions at Deutsche Bank. Robert Ghenchev holds a Master of Financial Economics from Saïd Business School, University of Oxford, and a Bachelor of Arts and Bachelor of Commerce in Economics and Finance from McGill University.
This person is not in the org chart
This person is not in any teams